Beginner
- Dose
- 20 mg por dia Original in PT-BR
- Frequency
- Diária Original in PT-BR
- Duration
- Semana 1 Original in PT-BR
- Notes
- A tabela do site também apresenta a equivalência aproximada para solução de 215,2 mg/mL. Original in PT-BR
KNOWLEDGE · COMPOUNDS
Cerebrolysin
CognitiveClinical trials
Overview
Written by EagleThis description was written by Eagle in each of the three languages. It is not imported text and carries no translation warning. What it says comes from the compound’s own composition, its pharmacological class and what the library records — no efficacy claim, and no Eagle recommendation of use.
Referência de pesquisa sobre doses e contextos clínicos históricos; não é uma recomendação individual.
Cerebrolysin is catalogued under Cognitive. 0 Eagle articles in this library reference this compound.
- Category
- Cognitive
- Research stage
- Clinical trials — Contextos clínicos publicados Original in PT-BR
- Eagle articles on this compound
- 0 Eagle articles
Mechanism
O site descreve Cerebrolysin como uma preparação neurotrófica de pesquisa, administrada por infusão intravenosa ou via intramuscular. Original in PT-BR
Chemical information
- CAS
- Not recorded in the source.
- Molecular formula
- Not recorded in the source.
- Molecular weight
- Not recorded in the source.
- Sequence
- Not recorded in the source.
- Amino acids
- Not recorded in the source.
- Solubility
- Not recorded in the source.
- Stability
- Not recorded in the source.
- Half-life
- Not recorded in the source.
- Bioavailability
- Not recorded in the source.
- Onset
- Not recorded in the source.
- Routes
- Intravenosa · Intramuscular
Research references
No individual dosing recommendation is given. Values are as recorded in the source, with species and route stated where known.
No research references recorded in the source.
Safety
No safety information recorded in the source.
Reported protocols
Recorded in the imported source as community protocols. They are NOT Eagle protocols, were not reviewed by Eagle, and are not a dosing recommendation, a prescription or clinical guidance. Values appear exactly as recorded, in the language they were written in.
Intermediate
- Dose
- 24–28 mg por dia Original in PT-BR
- Frequency
- Diária Original in PT-BR
- Duration
- Semanas 2–3 Original in PT-BR
- Notes
- Semana 2: 24 mg/dia; semana 3: 28 mg/dia. Original in PT-BR
Advanced
- Dose
- 32 mg por dia Original in PT-BR
- Frequency
- Diária Original in PT-BR
- Duration
- Semana 4 em diante Original in PT-BR
- Notes
- O site separa esse planejamento de contextos históricos de 5–30 mL IV/IM. Original in PT-BR
Vial sizes: 60 mg — Peptide Calculator
Interactions
No relations recorded in the source.
Related
No Eagle article in this library references this compound yet.